Treatment for extreme drug-resistant tuberculosis wins US government approval
The US Food and Drug Administration has approved a drug regimen to treat an extreme form of multi-drug-resistant tuberculosis (TB).
Nearly 90% of people infected with extensively drug-resistant (XDR) TB who took this treatment during a clinical trial recovered in 6 months. The average success rate for drug regimens currently used to treat XDR TB is around 34%
Join the AMR Insights Ambassador Network today!
Connect to over 650 AMR professionals and students in 65 countries!